Compare · ELV vs SERA
ELV vs SERA
Side-by-side comparison of Elevance Health Inc. (ELV) and Sera Prognostics Inc. (SERA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ELV and SERA operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $92.91B, about 1160.2x SERA ($80.1M).
- ELV has been more active in the news (3 items in the past 4 weeks vs 1 for SERA).
- ELV has more recent analyst coverage (23 ratings vs 8 for SERA).
- Company
- Elevance Health Inc.
- Sera Prognostics Inc.
- Price
- $428.56+0.04%
- $2.04-0.97%
- Market cap
- $92.91B
- $80.1M
- 1M return
- -
- -1.45%
- 1Y return
- -
- -36.05%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 3
- 1
- Recent ratings
- 23
- 8
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Sera Prognostics Inc.
Sera Prognostics, Inc., a health diagnostic company, discovers, develops, and commercializes biomarker tests for the early prediction of preterm birth risk and other complications of pregnancy. It develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Latest ELV
- SEC Form 4 filed by Elevance Health Inc.
- Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2026 Results on October 21, 2026
- Elevance Health’s Affiliated 2027 Medicare Advantage Plans Advance Stability, Choice and More Coordinated Support
- Elevance Health Inc. filed SEC Form 8-K: Regulation FD Disclosure
- EVP & Chief Legal Officer Wessling Erin M covered exercise/tax liability with 349 shares, decreasing direct ownership by 5% to 7,230 units (SEC Form 4)
- EVP & Chief HR Officer Craig Ryan R covered exercise/tax liability with 144 shares, decreasing direct ownership by 2% to 6,530 units (SEC Form 4)
- Elevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health Journey
- Director Peru Ramiro G bought $366,050 worth of shares (1,000 units at $366.05), increasing direct ownership by 10% to 10,908 units (SEC Form 4)
- President and CEO Boudreaux Gail bought $1,002,230 worth of shares (2,725 units at $367.79), increasing direct ownership by 2% to 171,976 units (SEC Form 4)
- SEC Form 10-Q filed by Elevance Health Inc.
Latest SERA
- SEC Form 4 filed by Sera Prognostics Inc.
- Chief Executive Officer Lindgardt Zhenya sold $14,044 worth of shares (7,022 units at $2.00), decreasing direct ownership by 0.83% to 837,848 units (SEC Form 4) to satisfy withholding tax
- General Counsel Jackson Benjamin sold $4,380 worth of shares (2,190 units at $2.00), decreasing direct ownership by 1% to 159,566 units (SEC Form 4) to satisfy withholding tax
- Chief Commercial Officer Anderson Dyaarl Lee Jr. sold $3,600 worth of shares (1,800 units at $2.00), decreasing direct ownership by 2% to 76,198 units (SEC Form 4) (withholding tax)
- Chief Medical Officer Inglis Tiffany Eul Davis sold $972 worth of shares (486 units at $2.00), decreasing direct ownership by 0.53% to 91,589 units (SEC Form 4) to satisfy withholding obligation
- Chief Executive Officer Lindgardt Zhenya sold $40,278 worth of shares (20,139 units at $2.00), decreasing direct ownership by 2% to 844,870 units (SEC Form 4) (for withholding tax)
- SEC Form 4 filed by Chief Financial Officer Aerts Austin
- SEC Form 3 filed by new insider Gleason Scott
- Chief Financial Officer Gleason Scott was granted 117,924 shares (SEC Form 4)
- 1 in 10 U.S. Babies Are Born Too Early. A Leading OB-GYN Says Most Mothers Can Learn Their Risk by Week 21, and Do Something About It.